about
The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cellsPancreatic cancer stem cell markers and exosomes - the incentive pushAberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast CancerMicroRNAs in breast cancer initiation and progressionCD44, Hyaluronan, the Hematopoietic Stem Cell, and Leukemia-Initiating CellsLoss of the novel tumour suppressor and polarity gene Trim62 (Dear1) synergizes with oncogenic Ras in invasive lung cancerInhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides.p53Ψ is a transcriptionally inactive p53 isoform able to reprogram cells toward a metastatic-like state.Fish oil prevents breast cancer cell metastasis to bone.CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progressionSimvastatin prevents skeletal metastasis of breast cancer by an antagonistic interplay between p53 and CD44.Downregulation of CD44 reduces doxorubicin resistance of CD44CD24 breast cancer cellsCD44v6 expression in patients with stage II or stage III sporadic colorectal cancer is superior to CD44 expression for predicting progressionThe liberation of CD44.Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expressionCD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcomaCD44 Promotes Epithelial Mammary Gland Development and Exhibits Altered Localization during Cancer ProgressionGrowth factor signaling induces metastasis genes in transformed cells: molecular connection between Akt kinase and osteopontin in breast cancerSignificance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguityCaffeic Acid Phenethyl Ester (CAPE) derived from propolis, a honeybee product, inhibits growth of breast cancer stem cells.Metastatic and prognostic factors in patients with alveolar echinococcosis.Role of VEGF and CD44v6 in differentiating benign from malignant ascites.BCc1, the novel antineoplastic nanocomplex, showed potent anticancer effects in vitro and in vivo.Hyaluronan as a therapeutic target in human diseasesA tissue-engineered subcutaneous pancreatic cancer model for antitumor drug evaluationLack of lymphatic vessel phenotype in LYVE-1/CD44 double knockout mice.DHA is a more potent inhibitor of breast cancer metastasis to bone and related osteolysis than EPA.Molecular mechanisms involved in mesenchymal stem cell migration to the site of acute myocardial infarctionCD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain.Effects of hyaluronic acid on mitochondrial function and mitochondria-driven apoptosis following oxidative stress in human chondrocytes.CD44v6-competent tumor exosomes promote motility, invasion and cancer-initiating cell marker expression in pancreatic and colorectal cancer cells.Protein kinase C epsilon and genetic networks in osteosarcoma metastasis.Promising noninvasive cellular phenotype in prostate cancer cells knockdown of matrix metalloproteinase 9
P2860
Q24595836-3730C020-A4F3-4FDF-91A9-B5E155C11CE4Q26741215-F04E35FE-B64C-4C58-9168-519F97BDF5F4Q26773907-C0D3F667-DEE2-4ED0-8192-C4B0C8434794Q26823360-693EFE45-ECD2-4C51-8F22-9C8959465C3FQ28084610-90376018-0696-44C1-B1EA-93BA2B8ED7ECQ28505734-809F6119-1502-454C-8576-CBE13AD04FF2Q30478184-0233F7A6-94D1-4A0C-AD51-719D99D7B817Q34060903-8D038470-2A05-4D74-9F2B-F633C7D0CE5EQ34361670-5DBE34B5-7E68-472D-8E21-A0BE4535C7CBQ34627193-D7E6F47E-CB92-422E-840D-6B48BB453B92Q34719626-30EFD700-0614-42D4-A556-990E06ACCEBDQ35128711-11742973-CD71-48FD-9140-FDE9CAB79EA2Q35145123-6DDD964F-853E-4714-B660-76407FF1F411Q35149561-CEB5CA83-DC14-467D-BFC9-76D997BA74E7Q35568362-C4DE1BC8-8FBA-4066-9D93-605D3010C418Q35746515-738E8AEC-53E8-454C-AE13-02092E15C352Q35755182-38F2381D-A2B7-425F-AA22-A93DD852271CQ35920825-5511B487-68FA-43CF-A376-58CFC4275DBAQ36014411-6B279670-60B5-4FFE-8487-033BC9FD7DDCQ36072049-02226B6D-5A69-48BA-B4DA-974E3AA3D234Q36261700-B3FFA6D6-407E-4AFC-BF48-327969E1C857Q36308920-0ABA61FA-C2FD-4229-B1FA-F0F12296C810Q36425426-263BEE8F-60FD-4E4F-AFCC-40551AD87C5DQ36578627-1B6C5321-FC12-4060-B518-FEB15D23F0FFQ36714052-EB1212AA-F06E-4D2C-B43F-9B1113534A86Q37149415-144F3B60-2420-469E-8CD3-59AE8948BA26Q37339672-CECD7233-FDAD-42CE-8361-2BEA83E91267Q37687143-A905B07D-D96C-47B5-958E-7FF49E09BB58Q39647831-B74EE72E-A3D2-42E4-926C-4511A445F6ADQ41827270-E66FC664-CEB4-4D50-BA63-17DA01C12603Q41849010-232891F7-9F21-4ED4-ADD5-B5918E30C787Q42265507-52CE5C13-6D1C-40C7-A09D-EF73F8E67496Q59033916-104FF444-9059-4E6A-9493-F885157F8FF3
P2860
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Absence of the CD44 gene prevents sarcoma metastasis.
@en
Absence of the CD44 gene prevents sarcoma metastasis.
@nl
type
label
Absence of the CD44 gene prevents sarcoma metastasis.
@en
Absence of the CD44 gene prevents sarcoma metastasis.
@nl
prefLabel
Absence of the CD44 gene prevents sarcoma metastasis.
@en
Absence of the CD44 gene prevents sarcoma metastasis.
@nl
P2093
P1433
P1476
Absence of the CD44 gene prevents sarcoma metastasis
@en
P2093
Georg F Weber
Harvey Cantor
John Ilagan
Roderick T Bronson
Rudolf Schmits
P304
P407
P577
2002-04-01T00:00:00Z